Amgen issued an 8-K on October 27, 2026, announcing that its Board of Directors declared a quarterly cash dividend of $2.52 per share for the fourth quarter of 2026.

Key Highlights

  • Dividend amount: $2.52 per share declared for the fourth quarter of 2026.
  • Payment date: The dividend will be paid on December 11, 2026.
  • Record date: Stockholders of record as of the close of business on November 20, 2026 are eligible.
  • Declaration body: Amgen's Board of Directors approved the dividend.
  • Exchange and ticker: Amgen trades on NASDAQ:AMGN.

Amgen Board Sets Fourth-Quarter 2026 Cash Dividend Terms

According to the filing, Amgen's Board of Directors declared a $2.52 per share cash dividend for the fourth quarter of 2026. The announcement was made from the company's headquarters in Thousand Oaks, California, on October 27, 2026. The filing identifies Amgen as a component of the Dow Jones Industrial Average and the Nasdaq-100 Index.

The filing states that the dividend will be paid on December 11, 2026, to all stockholders of record as of the close of business on November 20, 2026. No additional conditions or qualifications to the payment were described in the disclosure beyond the record date and payment date.

The news release includes forward-looking statements, which the company states "are based on the current expectations and beliefs of Amgen" and are subject to significant risks and uncertainties. Among the risks cited, the filing notes that "our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock." Investors are directed to Amgen's most recent annual report on Form 10-K and subsequent periodic reports for a fuller description of those risks.

What Was Disclosed

Amgen disclosed that its Board of Directors declared a $2.52 per share dividend for the fourth quarter of 2026, payable December 11, 2026, to stockholders of record as of November 20, 2026.